Which crop, which claim

You have data from somewhere else, a mechanism you can defend, and a plan built where the product was developed.

Then Brazil comes up, and two questions arrive at once.

Which crop the product should enter first. And what the product should be registered as.

Most companies treat the first as agronomy and the second as paperwork. The crop map comes back full, because Brazil has the pest, the deficiency or the stress almost everywhere, so the choice falls to trial availability or to whoever answered the email. The registration question goes to a regulatory adviser, who recommends the fastest defensible route.

A biostimulant, a seed treatment, a fertiliser, a biological, an adjuvant. Most products with a regulatory route in Brazil have more than one legal identity available.

The route decides which claims you can print. The claims decide which shelf the product sits on. The shelf decides who you compete with, and what price survives the comparison.

The shortest route is usually the most crowded one. Twelve months into a shelf full of cheap generics can cost more than four years into a category with three players.

It deserves to be made with the commercial case on the table, and it rarely is.

Under the crop protection framework, registration and trials are committed per crop.

Under the bioinput and fertiliser frameworks, the commitment is the claim: the guarantees, the specifications and the studies behind them.

Either way, the distributor you sign has a portfolio built per crop, and a sales team that can carry one new story per cycle.

Change the crop or the claim after any of that is committed, and most of it resets.